If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
5
Followers on Owler
Cellmid
is an Australian company that is engaged in the development of antibodies for midkine...
Read more
Overview
Acquisitions
Funding
News & Insights
Cellmid
is an Australian company that is engaged in the development of antibodies for midkine...
Read more
CEO
- -
CEO Approval Rating
- -/100
2014
Sydney
Nova Scotia
Public
Australian Securities Exchange
CDY
Pharmaceuticals & Biotechnology
- -
2836
NAICS listing
http://cellmid.com.au/
Annual Revenue
<$1M
Employees
<10
Funding
$24.1M
Acquisitions
1
News
Latest News
Mar 25, 2021
ChinaPulse
Cellmid: Cellmid receives further boost to cash balance with R&D tax credit
Dec 14, 2020
FinTech InShorts
Cellmid: Cellmid: Signs 10 year Chinese distribution agreemen -
Dec 14, 2020
Kalkine Media
Cellmid: Cellmid forays into Chinese market with exclusive agreement
Sep 10, 2020
News n Releases
Press Release: Cellmid : Cellmid engages advisers to facilitate divestment from its subsidiary
Jul 09, 2020
Business News Australia
Cellmid: Cellmid pens agreement to ramp up COVID-19 research
Jun 16, 2020
The Market Herald
Cellmid: Cellmid (ASX:CDY) reports strong Japanese television channel sales
Jun 04, 2020
FinTech InShorts
Cellmid: Cellmid: Signs agreement with Emergence Technology for SARS-CoV-2 tests -
Apr 14, 2020
FinTech InShorts
Cellmid: Cellmid: Receives first shipment of SARS-CoV-2 tests - FinTech News In Shorts
Mar 31, 2020
Business News Australia
Cellmid: 15-minute coronavirus test turns fortunes for Cellmid
Mar 30, 2020
Stockhead
Cellmid: Cellmid shares jump after securing deal on Chinese COVID-19 testing kits
Follow and Get Alerts
Trending Companies